what-when-how
In Depth Tutorials and Information
[8] Elder DE, Elenitsas R, Lever WF. Lever's histopathology of
the skin, 10th ed. Philadelphia, Pa.; London: Wolters Kluwer/
Lippincott Williams & Wilkins; 2009.
[9] Tanaka Y, Matsuo K, Yuzuriha S, Shinohara H. Differential long-
term stimulation of type I versus type III collagen after infrared
irradiation. Dermatol Surg 2009;35(7):1099-104.
[32]
Carey TD. Elastosis perforans serpiginosa. Arch Dermatol
1977;113(10):1444-5.
[33]
Mehregan AH. Elastosis perforans serpiginosa: a review of the lit-
erature and report of 11 cases. Arch Dermatol 1968;97(4):381-93.
[34]
Barr RJ, Siegel JM, Graham JH. Elastosis perforans serpiginosa
associated with morphea. An example of “performing mor-
phea.” J Am Acad Dermatol 1980;3(1):19-22.
[10]
Spitz JL. Genodermatoses: A full-color clinical guide to genetic skin
disorders . Baltimore; London: Williams & Wilkins; 1996.
[35]
May NC, Lester RS. Elastosis perforans serpiginosa associated
with systemic sclerosis. J Am Acad Dermatol 1982;6(5):945.
[11]
Francis MJ, Williams KJ, Sykes BC, Smith R. The relative amounts
of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the
skin of 31 patients with osteogenesis imperfecta. Clin Sci (Lond)
1981;60(6):617-23.
[36]
McCullough JL, Kelly KM. Prevention and treatment of skin
aging. Ann N Y Acad Sci 2006;1067:323-31.
[37]
Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al.
Mechanisms of photoaging and chronological skin aging. Arch
Dermatol 2002;138(11):1462-70.
[12]
Hansen B, Jemec GB. The mechanical properties of skin in osteo-
genesis imperfecta. Arch Dermatol 2002;138(7):909-11.
[13]
Wong RS, Follis FM, Shively BK, Wernly JA. Osteogenesis
imperfecta and cardiovascular diseases. Ann Thorac Surg
1995;60(5):1439-43.
[38]
Linos E, Keiser E, Kanzler M, Sainani KL, Lee W, Vittinghoff E,
et  al. Sun protective behaviors and vitamin D levels in the US
population: NHANES 2003-2006. Cancer Causes Control 2012;
23(1):133-40.
[14]
Woolley MM, Morgan S, Hays DM. Heritable disorders of con-
nective tissue. Surgical and anesthetic problems. J Pediatr Surg
1967;2(4):325-31.
[39]
Lim HW, Gilchrest BA, Cooper KD, Bischoff-Ferrari HA, Rigel
DS, Cyr WH, et  al. Sunlight, tanning booths, and vitamin D.
J Am Acad Dermatol 2005;52(5):868-76.
[15]
Hathaway WE, Solomons CC, Ott JE. Platelet function and pyro-
phosphates in osteogenesis imperfecta. Blood 1972;39(4):500-9.
[40]
Scholes KT, Crow KD, Ellis JP, Harman RR, Saihan EM. Axillary
hyperhidrosis treated with alcoholic solution of aluminium
chloride hexahydrate. Br Med J 1978;2(6130):84-5.
[16]
Burnei G, Vlad C, Georgescu I, Gavriliu TS, Dan D. Osteogenesis
imperfecta: diagnosis and treatment. J Am Acad Orthop Surg
2008;16(6):356-66.
[41]
Reinauer S, Neusser A, Schauf G, Holzle E. Iontophoresis with
alternating current and direct current offset (AC/DC iontopho-
resis): a new approach for the treatment of hyperhidrosis. Br J
Dermatol 1993;129(2):166-9.
[17]
Shoenfeld Y. Osteogenesis imperfecta. Review of the literature
with presentation of 29 cases. Am J Dis Child 1975;129(6):679-87.
[18]
White H. Elastosis perforans serpiginosa. Arch Dermatol
1970;102(1):123-4.
[42]
Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum
toxin A for axillary hyperhidrosis (excessive sweating). N Engl J
Med 2001;344(7):488-93.
[19]
Vearrier D, Buka RL, Roberts B, Cunningham BB, Eichenield
LF, Friedlander SF. What is standard of care in the evaluation of
elastosis perforans serpiginosa? A survey of pediatric dermatol-
ogists. Pediatr Dermatol 2006;23(3):219-24.
[43]
Kim WO, Kil HK, Yoon KB, Yoon DM. Topical glycopyr-
rolate for patients with facial hyperhidrosis. Br J Dermatol
2008;158(5):1094-7.
[20]
Nicholls AC, Pope FM, Craig D. An abnormal collagen alpha
chain containing cysteine in autosomal dominant osteogenesis
imperfecta. Br Med J 1984;288(6411):112-3.
[44]
Kai R, Kwak HS, Schumacher WE, Cho S, Hanft VN, Hamilton
TA, et  al. Improvement of naturally aged skin with vitamin A
(retinol). Arch Dermatol 2007;143(5):606-12.
[21]
Klett CC. Hereditary disorders of connective tissue: a review.
Wound Repair Regen 1997;5(1):3-11.
[45]
Nelson DL, Balian G. The effect of retinoic acid on collagen
synthesis by human dermal ibroblasts. Coll Relat Res 1984;
4(2):119-28.
[22]
Francis MJ, Smith R, Bauze RJ. Instability of polymeric skin col-
lagen in osteogenesis imperfecta. Br Med J 1974;1(5905):421-4.
[23]
Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S,
Chung JH, et  al. Vitamin A antagonizes decreased cell growth
and elevated collagen-degrading matrix metalloproteinases and
stimulates collagen accumulation in naturally aged human skin.
J Invest Dermatol 2000;114(3):480-6.
[46]
Daly TJ, Weston WL. Retinoid effects on ibroblast proliferation
and collagen synthesis in vitro and on ibrotic disease in vivo.
J Am Acad Dermatol 1986;15(4 Pt 2):900-2.
[47]
Zussman J, Ahdout J, Kim J. Vitamins and photoaging: do sci-
entiic data support their use? J Am Acad Dermatol 2010;
63(3):507-25.
[24]
Francis MJ, Smith R. Polymeric collagen of skin in osteogenesis
imperfecta, homocystinuria and Ehlers-Danlos and Marfan syn-
dromes. Birth Defects Orig Artic Ser 1975;11(6):15-21.
[48]
Cho S, Lowe L, Hamilton TA, Fisher GJ, Voorhees JJ, Kang
S. Long-term treatment of photoaged human skin with topi-
cal retinoic acid improves epidermal cell atypia and thickens
the collagen band in papillary dermis. J Am Acad Dermatol
2005;53(5):769-74.
[25]
Reed WB, Pidgeon JW. Elastosis perforans serpiginosa with
osteogenesis imperfecta. Arch Dermatol 1964;89:342-4.
[26]
Weedon D. Weedon's skin pathology. Amsterdam: Churchill
Livingston Elsevier; 2010.
[49]
Grifiths CE, Russman AN, Majmudar G, Singer RS, Hamilton
TA, Voorhees JJ. Restoration of collagen formation in photo-
damaged human skin by tretinoin (retinoic acid). N Engl J Med
1993;329(8):530-5.
[27]
Talwar HS, Grifiths CE, Fisher GJ, Hamilton TA, Voorhees
JJ. Reduced type I and type III procollagens in photodamaged
adult human skin. J Invest Dermatol 1995;105(2):285-90.
[28]
Oikarinen A, Autio P. New aspects of the mechanism of corticoste-
roid-induced dermal atrophy. Clin Exp Dermatol 1991;16(6):416-9.
[50]
Kang S, Duell EA, Fisher GJ, Datta SC, Wang ZQ, Reddy AP,
et  al. Application of retinol to human skin in vivo induces epi-
dermal hyperplasia and cellular retinoid binding proteins char-
acteristic of retinoic acid but without measurable retinoic acid
levels or irritation. J Invest Dermatol 1995;105(4):549-56.
[29]
Espinosa PS, Baumann RJ, Vaishnav AG. Elastosis perforans
serpiginosa, Down syndrome, and moyamoya disease. Pediatr
Neurol 2008;38(4):287-8.
[30]
Siragusa M, Romano C, Cavallari V, Schepis C. Localized elasto-
sis perforans serpiginosa in a boy with Down syndrome. Pediatr
Dermatol 1997;14(3):244-6.
[51]
Rosenblum GA. Liquid nitrogen cryotherapy in a case
of elastosis perforans serpiginosa. J Am Acad Dermatol
1983;8(5):718-21.
[31]
Mehta RK, Burrows NP, Payne CM, Mendelsohn SS, Pope FM,
Rytina E. Elastosis perforans serpiginosa and associated disor-
ders. Clin Exp Dermatol 2001;26(6):521-4.
[52]
Outland JD, Brown TS, Callen JP. Tazarotene is an effective ther-
apy for elastosis perforans serpiginosa. Arch Dermatol 2002;
138(2):169-71.
Search WWH ::




Custom Search